All Stories

  1. Transmission Ratio Distortion in Genetic Prion Diseases: Clarifying Methodological Considerations
  2. The Risk of Transmission of Genetic Prion Diseases is Greater Than 50%
  3. Genetic counselling in the era of next generation sequencing
  4. Heterodisomy in the GNAS locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3)
  5. Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis
  6. Colonic adenomatous polyp with florid presence of monoclonal lambda Russell bodies: Case report and etiopathogenic hypothesis
  7. Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report
  8. Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune–Albright Syndrome (FD/MAS)
  9. Deficiencia de vitamina D en la edad adulta: presentación de 2 casos familiares de seudohipoparatiroidismo
  10. The Human Phenotype Ontology in 2024: phenotypes around the world
  11. Incidental finding at methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA): how to proceed?
  12. El enigma de la enfermedad de Enrique IV, rey de Castilla: ¿padeció síndrome de McCune-Albright/displasia fibrosa?
  13. C9ORF72 Gene GGGGCC Hexanucleotide Expansion: A High Clinical Variability from Amyotrophic Lateral Sclerosis to Frontotemporal Dementia
  14. Nutrition recommendations for patients with pseudohypoparathyroidism
  15. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations
  16. Imprinting disorders
  17. New pathogenic variant in DLX5: New clues for a clinical spectrum from split-hand-foot malformation to fibular aplasia, tibial campomelia and oligosyndactyly
  18. Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis
  19. Frequency of de novo variants and parental mosaicism in families with inactivating PTH/PTHrP signaling disorder type 2
  20. Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value
  21. First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders
  22. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
  23. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease
  24. Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences
  25. Congenital cutaneous ossification
  26. Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period
  27. Gernutik lortutako zelula ama mesenkimalak (hUSC) pseudohipoparatiroidismoaren (PHP) terapia geniko ez-biralerako
  28. Design and Validation of a Process Based on Cationic Niosomes for Gene Delivery into Novel Urine-Derived Mesenchymal Stem Cells
  29. Inactivating PTH/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients
  30. Novel Variant in PLAG1 in a Familial Case with Silver–Russell Syndrome Suspicion
  31. Prenatal and foetal autopsy findings in glutaric aciduria type II
  32. Clinical and Molecular Description of 16 Families With Heterozygous IHH Variants
  33. Hereditary Spastic Paraplegia and Intellectual Disability: Clinicogenetic Lessons From a Family Suggesting a Dual Genetics Diagnosis
  34. Glucose and galactose malabsorption: A new case in Spain
  35. Malabsorción de glucosa y galactosa. Nuevo caso en España
  36. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes
  37. Implicaciones en pediatría del primer consenso internacional para el diagnóstico y asistencia a pacientes con pseudohipoparatiroidismo y enfermedades relacionadas
  38. Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders
  39. Cri-du-chat syndrome mimics Silver-Russell syndrome depending on the size of the deletion: a case report
  40. Impaired proteostasis in rare neurological diseases
  41. Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review
  42. Craniofacial fibrous dysplasia and long-term untreated GH excess in McCune-Albright syndrome
  43. Progressive osseous heteroplasia caused by a mosaic GNAS mutation
  44. What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis
  45. Braquidactilia tipo C debida a mutación de parada en el gen GDF5
  46. Brachydactyly type C due to a nonsense mutation in the GDF5 gene
  47. The Use of Methylation-Sensitive Multiplex Ligation-Dependent Probe Amplification for Quantification of Imprinted Methylation
  48. Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3
  49. Intratumoral activating GNAS (R201C) mutation in two unrelated patients with virilizing ovarian Leydig cell tumors
  50. The p.R56* mutation in PTHLH causes variable brachydactyly type E
  51. Fe de errores de «Seudoseudohipoparatiroidismo frente a heteroplasia ósea progresiva en ausencia de historia familiar» [Med Clin (Barc). 2015;145(10):e25-e27]
  52. Erratum to “Pseudopseudohypoparathyroidism vs. progressive osseous heteroplasia in absence of family history” [Med Clin (Barc). 2015;145(10):e25–e27]
  53. Familial Progressive Hyperpigmentation, Cutaneous Mastocytosis, and Gastrointestinal Stromal Tumor as Clinical Manifestations of Mutations in the c-KIT Receptor Gene
  54. The Prevalence ofGNASDeficiency-Related Diseases in a Large Cohort of Patients Characterized by the EuroPHP Network
  55. Clinical and molecular analyses of Beckwith-Wiedemann syndrome: Comparison between spontaneous conception and assisted reproduction techniques
  56. From pseudohypoparathyroidism to inactivating PTH/PTHrP signaling disorder (iPPSD), a novel classification proposed by the European EuroPHP-network
  57. The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network
  58. Marfan Syndrome Caused by Somatic Mosaicism in an FBN1 Splicing Mutation
  59. Síndrome de Marfan causado por mosaicismo somático de una mutación en splicing en FBN1
  60. Erratum to: Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci
  61. Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects
  62. Report of two novel mutations inPTHLHassociated with brachydactyly type E and literature review
  63. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci
  64. Seudoseudohipoparatiroidismo frente a heteroplasia ósea progresiva en ausencia de historia familiar
  65. Pseudopseudohypoparathyroidism vs progressive osseous heteroplasia in absence of family history
  66. European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
  67. Novel Microdeletions Affecting the GNAS Locus in Pseudohypoparathyroidism: Characterization of the Underlying Mechanisms
  68. Multilocus methylation defects in imprinting disorders
  69. European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
  70. GATA4 Mutations Are a Cause of Neonatal and Childhood-Onset Diabetes
  71. Clinical utility gene card for: Transient Neonatal Diabetes Mellitus, 6q24-related
  72. Pseudohypoparathyrodism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  73. Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation
  74. Maternal Hypomethylation of KvDMR in a Monozygotic Male Twin Pair Discordant for Beckwith-Wiedemann Syndrome
  75. Simultaneous Hyper- and Hypomethylation at Imprinted Loci in a Subset of Patients withGNASEpimutations Underlies a Complex and Different Mechanism of Multilocus Methylation Defect in Pseudohypoparathyroidism Type 1b
  76. Disomy as the Genetic Underlying Mechanisms of Loss of Heterozigosity in SDHD-Paragangliomas
  77. Endocrine Profile and Phenotype-(Epi)Genotype Correlation in Spanish Patients with Pseudohypoparathyroidism
  78. GNAS (GNAS complex locus)
  79. Genome-Wide Allelic Methylation Analysis Reveals Disease-Specific Susceptibility to Multiple Methylation Defects in Imprinting Syndromes
  80. Brachydactyly E: isolated or as a feature of a syndrome
  81. PRKAR1AandPDE4DMutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance
  82. Clinical utility gene card for: Pseudohypoparathyroidism
  83. Array-based characterization of an interstitial de-novo deletion of chromosome 4q in a patient with a neuronal migration defect and hypocalcemia plus a literature review
  84. Detection of Hypomethylation Syndrome among Patients with Epigenetic Alterations at theGNASLocus
  85. Novel mutations in MEN1 , CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in...
  86. Permanent Neonatal Diabetes Caused by Creation of an Ectopic Splice Site within the INS Gene
  87. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: Evidence for an autosomal recessive form of PHP-Ib?
  88. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus
  89. Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine
  90. Diferente expresividad de la mutacion Asn264LysfsX35 del gen GNAS en una familia afecta de pseudohipoparatiroidismo
  91. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  92. Constitutional mosaic genome-wide uniparental disomy due to diploidisation: an unusual cancer-predisposing mechanism
  93. Clinical characterization of a girl with trisomy 20q13.2qter and monosomy 13q33.1qter: Delineating phenotype-genotype correlations
  94. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  95. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels
  96. New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism
  97. Heterozygous glucokinase mutations and birth weight in Spanish children
  98. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  99. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  100. The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue
  101. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis
  102. Familial Hyperinsulinism-Hyperammonemia Syndrome in a Family with Seizures: Case Report
  103. IntragenicGNASDeletion Involving Exon A/B in Pseudohypoparathyroidism Type 1A Resulting in an Apparent Loss of Exon A/B Methylation: Potential for Misdiagnosis of Pseudohypoparathyroidism Type 1B
  104. HETEROZYGOUS GLUCOKINASE MUTATIONS AND BIRTH WEIGHT IN SPANISH CHILDREN.
  105. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs  coding mutations and GNAS imprinting defects
  106. Mutations inMAFAandIAPPare not a common cause of monogenic diabetes
  107. Glibenclamide treatment in relapsed transient neonatal diabetes as a result of aKCNJ11activating mutation (N48D)
  108. Two cases of deletion 2q37 associated with segregation of an unbalanced translocation 2;21: choanal atresia leading to misdiagnosis of CHARGE syndrome
  109. Genética del seudohipoparatiroidismo: bases para el consejo genético
  110. New mutation type in pseudohypoparathyroidism type Ia
  111. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients
  112. ACTH-dependent precocious pseudopuberty in an infant with DAX1 gene mutation
  113. Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma
  114. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities
  115. Mutations in GCK and HNF-1? explain the majority of cases with clinical diagnosis of MODY in Spain
  116. Epigenetic Defects ofGNASin Patients with Pseudohypoparathyroidism and Mild Features of Albright’s Hereditary Osteodystrophy
  117. New ABCC8 Mutations in Relapsing Neonatal Diabetes and Clinical Features
  118. Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4
  119. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: Comparison of IgG and IgA
  120. Panhypopituitarism: Genetic Versus Acquired Etiological Factors
  121. No Association of TLR2 and TLR4 Polymorphisms with Type I Diabetes Mellitus in the Basque Population
  122. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes
  123. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease
  124. Functional Study of a Novel Single Deletion in theTITF1/NKX2.1Homeobox Gene That Produces Congenital Hypothyroidism and Benign Chorea But Not Pulmonary Distress
  125. Contribution of MIC-A Polymorphism to Type 1 Diabetes Mellitus in Basques
  126. Killer Cell Immunoglobulin-Like Receptor (KIR) Genes in the Basque Population: Association Study of KIR Gene Contents With Type 1 Diabetes Mellitus
  127. Neoplasia endocrina múltiple: estudio genético
  128. Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus
  129. No Association ofINS-VNTR Genotype and IAA Autoantibodies
  130. Short CommunicationNo Evidence of Association ofCTLA4Polymorphisms with Addison's Disease
  131. 5′-Insulin Gene VNTR Polymorphism Is Specific for Type 1 Diabetes
  132. HLA-DRB1 andMICAin Autoimmunity
  133. No Association of CTLA4 Gene With Celiac Disease in the Basque Population
  134. A submicroscopic deletion of 11p13 associated with the WAGR syndrome
  135. Familial hypercalcemia and hypercalciuria: no mutations in the Ca 2+ -sensing receptor gene
  136. Analysis of Chromosome 6q in Basque Families with Type 1 Diabetes
  137. Excess Iron Storage in Patients with Type 2 Diabetes Unrelated to Primary Hemochromatosis
  138. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop)
  139. No evidence of association of chromosome 2 q with Type I diabetes in the Basque population
  140. A case of Prader-Willi syndrome associated with mosaicism: Cytogenetic and FISH study.